Squalamine

N/A

Report date: 2025/11/17 10:07:56
NME

Base Information

Drug NameSqualamine
Drug Alias Name司夸胺Squalamine lactate角鲨胺squalaminum角鲨胺乳酸 +[10] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionPlatelet-derived growth factor subunit A inhibitorsFibroblast growth factor 2 inhibitorsVascular endothelial growth factor inhibitors +[4] 
TargetsFibroblast growth factor 2Platelet-derived growth factor subunit BVascular endothelial growth factor +[4] 
Therapy Area/IndicationsRetinal Vein OcclusionWet age-related macular degenerationMacular Edema +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGenaera
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGenaera CorporationOhsu Knight Cancer InstituteOhr Pharmaceutical Inc +[4] 
Active IndicationsN/A
Inactive IndicationsRetinal Vein OcclusionWet age-related macular degenerationMacular Edema +[6] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG